首页> 外文期刊>Inside EPA's environmental policy alert >Questions Over Health Effects, Monitoring Complicate 'Ultrafine' PM Rules
【24h】

Questions Over Health Effects, Monitoring Complicate 'Ultrafine' PM Rules

机译:有关健康影响的问题,监控复杂的“超细” PM规则

获取原文
获取原文并翻译 | 示例
       

摘要

Questions over small "ultrafine" particulate matter's (UFP) exact adverse impacts on human health and uncertainty over how to monitor emissions of the pollutant remain unanswered despite new evidence of UFP's harms to humans, suggesting any first-time EPA regulation of the particles is unlikely in the near future. At the annual Health Effects Institute (HEI) conference here May 4-5, various speakers from EPA, industry and the scientific research community weighed the role of UFP compared to fine particulate matter (PM2.5) and larger coarse particulate matter (PM10) that EPA already regulates with national ambient air quality standards (NAAQS). UFP is smaller than either PM2.5 and PM10, but the agency has no NAAQS or other rules to control it.
机译:尽管有新的证据表明UFP对人体有害,但仍未回答关于小的“超细”颗粒物(UFP)对人体健康的确切不利影响以及如何监控污染物排放的不确定性的疑问,这表明首次对微粒进行EPA首次监管的可能性不大在不远的将来。在5月4日至5日举行的年度健康影响研究所(HEI)会议上,来自EPA,行业和科研界的各种发言人对UFP与细颗粒物(PM2.5)和较大的粗颗粒物(PM10)的作用进行了权衡。 EPA已按照国家环境空气质量标准(NAAQS)进行监管。 UFP小于PM2.5和PM10,但该机构没有NAAQS或其他规则来控制它。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号